name:-0.33847379684448
name:-0.11869311332703
name:-0.0039899349212646
AGY THERAPEUTICS, INC. Patent Filings

AGY THERAPEUTICS, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for AGY THERAPEUTICS, INC..The latest application filed is for "piperazine and piperidine derivatives".

Company Profile
0.12.11
  • AGY THERAPEUTICS, INC. - South San Francisco CA
  • AGY Therapeutics, Inc. -
  • AGY Therapeutics, Inc. - 290 Utah Avenue South San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Piperazine and Piperidine Derivatives
App 20100256162 - Sun; Connie L
2010-10-07
Use of protein biomolecular targets in the treatment and visualization of brain tumors
Grant 7,060,275 - Mueller , et al. June 13, 2
2006-06-13
Use of biomolecular targets in the treatment and visualization of brain tumors
Grant 7,014,838 - Mueller , et al. March 21, 2
2006-03-21
High-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity
Grant 6,977,142 - Huang , et al. December 20, 2
2005-12-20
Interaction of NMDA receptor with protein tyrosine phosphatase
App 20050266509 - Jerecic, Jasna ;   et al.
2005-12-01
Interaction of NMDA receptor with the protein tyrosine phosphatase step in psychotic disorders
App 20050221411 - Braithwaite, Steven ;   et al.
2005-10-06
High-throughput transcriptome and functional validation analysis
Grant 6,924,109 - Melcher , et al. August 2, 2
2005-08-02
Interaction of NMDA receptor with the protein tyrosine phosphatase step in psychotic disorders
App 20050142630 - Braithwaite, Steven ;   et al.
2005-06-30
Treatment of neurologic disorders with inhibitors of 11beta-HSD1
App 20050137209 - Oksenberg, Donna ;   et al.
2005-06-23
Regulated nucleic acids in pathogenesis of alzheimer's disease
App 20050123962 - Gan, Li ;   et al.
2005-06-09
Interaction of NMDA receptor with protein tyrosine phosphatase
App 20050118644 - Jerecic, Jasna ;   et al.
2005-06-02
Combination of solubility and membrane permeability measurement methods for profiling of chemical compounds
App 20050106745 - Wexler, David ;   et al.
2005-05-19
Automated pathway recognition system
Grant 6,876,930 - Murray , et al. April 5, 2
2005-04-05
In vitro ischemia model
Grant 6,846,641 - Wieloch , et al. January 25, 2
2005-01-25
High-throughput transcriptome and functional validation analysis
Grant 6,841,351 - Gan , et al. January 11, 2
2005-01-11
Method of diagnosing ischemic stroke via UCP-2 detection
Grant 6,670,138 - Gonzalez-Zulueta , et al. December 30, 2
2003-12-30
Diagnostic marker for neurological conditions
Grant 6,660,483 - Kask , et al. December 9, 2
2003-12-09
Techniques for facilitating identification of candidate genes
App 20030054394 - Chin, Daniel J. ;   et al.
2003-03-20
Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1
Grant 6,521,414 - Melcher , et al. February 18, 2
2003-02-18
High-throughput transcriptome and functional validation analysis
App 20030027168 - Gan, Li ;   et al.
2003-02-06
Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
App 20020172958 - Gonzalez-Zulueta, Mirella ;   et al.
2002-11-21
Techniques for facilitating identification of candidate genes
Grant 6,470,277 - Chin , et al. October 22, 2
2002-10-22
Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors
Grant 6,455,026 - Mueller , et al. September 24, 2
2002-09-24
Company Registrations
SEC0001094567AGY THERAPEUTICS INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed